Changchun High-Tech Industry Group Co Ltd. Stock Analysis 000661.SZ

Changchun High-Tech Industry (Group) Co., Ltd. engages in the research and development, production, and sale of biopharmaceuticals and proprietary chinese medicines. The company is headquartered in Changchun, Jilin and currently employs 10,080 full-time employees. The firm mainly operates its business through three segments. The Pharmaceuticals segment is engaged in the research and development, production and sale of genetically engineered biological drugs, human vaccines, traditional Chinese medicines, and chemical drugs. The Real Estate segment is engaged in the development and sale of real estate. The Services segment is engaged in the provision of scientific research and technical services, leasing and business services. The firm's products include growth hormone series products, follicle-stimulating hormone, varicella live attenuated vaccine, freeze-dried nasal spray influenza live attenuated vaccine, Yinhua Miyanling tablets and other products. The firm conducts its business in the domestic and overseas markets.